Salivary adenoid cystic carcinoma in Denmark 1990–2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)

Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be conside...

Full description

Saved in:

Bibliographic Details
Published in:	Oral oncology Vol. 51; no. 12; pp. 1138 - 1142
Main Authors:	Bjørndal, Kristine, Krogdahl, Annelise, Therkildsen, Marianne H, Charabi, Birgitte, Kristensen, Claus A, Andersen, Elo, Schytte, Sten, Primdahl, Hanne, Johansen, Jørgen, Pedersen, Henrik B, Andersen, Lisbeth J, Godballe, Christian
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-12-2015
Subjects:	Adenoid cystic carcinoma Adolescent Adult Aged Aged, 80 and over Carcinoma, Adenoid Cystic - mortality Carcinoma, Adenoid Cystic - therapy Child Denmark - epidemiology Female Hematology, Oncology and Palliative Medicine Humans Male Middle Aged National Neoplasm Recurrence, Local - mortality Otolaryngology Prognosis Radiotherapy Radiotherapy, Adjuvant Salivary Gland Neoplasms - mortality Salivary Gland Neoplasms - therapy Survival Analysis Treatment Young Adult Prognosis Treatment National Radiotherapy Adenoid cystic carcinoma
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be considered in selected patients.
AbstractList	AIMTo describe outcome and prognostic factors, including the effect of radiotherapy, in a consecutive national series of salivary gland adenoid cystic carcinomas.METHODSFrom the national Danish salivary gland carcinoma database in the structure of DAHANCA, 201 patients diagnosed with adenoid cystic carcinoma, and treated with a curative intent, were identified in the period between 1990 and 2005. Variables necessary for statistical analyses were extracted from the database.RESULTSThe 10-year crude survival and disease specific survival rates were 58% and 75%, respectively. The 10-year locoregional control rate was 70%, and 36% of patients experienced a recurrence during follow-up (median 7.5 years); 18% developed distant metastases (most commonly to the lungs). In multivariate analysis, stage and margin status were both important factors with regards to survival and locoregional control. Radiotherapy did not improve survival, but it did improve the locoregional control rate.CONCLUSIONSThe treatment of choice is surgery with as wide margins as possible including elective, selective neck dissection. Adjuvant radiotherapy should be considered in patients with incomplete tumor resection, high disease stages, and tumors with a solid growth pattern. To describe outcome and prognostic factors, including the effect of radiotherapy, in a consecutive national series of salivary gland adenoid cystic carcinomas. From the national Danish salivary gland carcinoma database in the structure of DAHANCA, 201 patients diagnosed with adenoid cystic carcinoma, and treated with a curative intent, were identified in the period between 1990 and 2005. Variables necessary for statistical analyses were extracted from the database. The 10-year crude survival and disease specific survival rates were 58% and 75%, respectively. The 10-year locoregional control rate was 70%, and 36% of patients experienced a recurrence during follow-up (median 7.5 years); 18% developed distant metastases (most commonly to the lungs). In multivariate analysis, stage and margin status were both important factors with regards to survival and locoregional control. Radiotherapy did not improve survival, but it did improve the locoregional control rate. The treatment of choice is surgery with as wide margins as possible including elective, selective neck dissection. Adjuvant radiotherapy should be considered in patients with incomplete tumor resection, high disease stages, and tumors with a solid growth pattern. Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced recurrence during follow-up (median 7.5 years). • The treatment of choice is surgery with free margins. • Adjuvant radiotherapy should be considered in selected patients. •A national Danish study presenting 201 patients with adenoid cystic carcinoma.•10-year disease specific survival was 75%.•36% experienced recurrence during follow-up (median 7.5years).•The treatment of choice is surgery with free margins.•Adjuvant radiotherapy should be considered in selected patients. To describe outcome and prognostic factors, including the effect of radiotherapy, in a consecutive national series of salivary gland adenoid cystic carcinomas. From the national Danish salivary gland carcinoma database in the structure of DAHANCA, 201 patients diagnosed with adenoid cystic carcinoma, and treated with a curative intent, were identified in the period between 1990 and 2005. Variables necessary for statistical analyses were extracted from the database. The 10-year crude survival and disease specific survival rates were 58% and 75%, respectively. The 10-year locoregional control rate was 70%, and 36% of patients experienced a recurrence during follow-up (median 7.5years); 18% developed distant metastases (most commonly to the lungs). In multivariate analysis, stage and margin status were both important factors with regards to survival and locoregional control. Radiotherapy did not improve survival, but it did improve the locoregional control rate. The treatment of choice is surgery with as wide margins as possible including elective, selective neck dissection. Adjuvant radiotherapy should be considered in patients with incomplete tumor resection, high disease stages, and tumors with a solid growth pattern.
Author	Krogdahl, Annelise Johansen, Jørgen Therkildsen, Marianne H Andersen, Elo Bjørndal, Kristine Kristensen, Claus A Andersen, Lisbeth J Godballe, Christian Primdahl, Hanne Pedersen, Henrik B Charabi, Birgitte Schytte, Sten
Author_xml	– sequence: 1 fullname: Bjørndal, Kristine – sequence: 2 fullname: Krogdahl, Annelise – sequence: 3 fullname: Therkildsen, Marianne H – sequence: 4 fullname: Charabi, Birgitte – sequence: 5 fullname: Kristensen, Claus A – sequence: 6 fullname: Andersen, Elo – sequence: 7 fullname: Schytte, Sten – sequence: 8 fullname: Primdahl, Hanne – sequence: 9 fullname: Johansen, Jørgen – sequence: 10 fullname: Pedersen, Henrik B – sequence: 11 fullname: Andersen, Lisbeth J – sequence: 12 fullname: Godballe, Christian
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26476712$$D View this record in MEDLINE/PubMed
BookMark	eNqNUstu1DAUjVARfcAvIItVWST4MY6TLpBGM9BBqlqJwtpy7JupZzL21E4qZcc_8E98CF-C0ykIsWJjWz7nnqN7zz3Njpx3kGVvCC4IJuW7TeGD6rzTvvPrsaCY8AQUGNNn2QmpRJ1jXrOj9GZllVdM8OPsNMYNxpgTjl9kx7SciVIQepL9uFWdfVBhRMqA89YgPcbeaqRV0Nb5nULWoSW4nQpbROoa__z2nSahC3Qz9NrvAClnEsfAHtLherQPfu38o0irdO9DTLDuBmPdGvV3gBpw0Noe-RYFZaxPf0HtxwJ9hjh0fZyAibdUzsY7tAJlHk2uQW_RQjkNAV0GP-zR-XK-ml8v5m9fZs9b1UV49XSfZV8_fviyWOVXN5efFvOrXHNM-pw2VGnBBdWEzDhr6tIoymeUE2gqxXHD2pZxyrWo6wa3FLOStSCqRrQ1g4ays-z8oJuavB8g9nJno4auUw78ECURTMwEZ7hO1IsDVQcfY4BW7oNNUxwlwXLKUW7k3znKKccJSzmm4tdPPkOzA_On9HdwibA8ECB1-2AhyKgtpNEYG0D30nj7fz7v_5HRnXVWq24LI8SNH4JL85RERiqxvJ02alqotEaYMUrZLxwdzk8
CitedBy_id	crossref_primary_10_1097_PAS_0000000000000918 crossref_primary_10_1007_s00428_018_2423_0 crossref_primary_10_1186_s40463_020_00446_1 crossref_primary_10_4103_crst_crst_284_23 crossref_primary_10_1016_j_hoc_2021_05_011 crossref_primary_10_2147_CMAR_S283494 crossref_primary_10_1002_cncy_21959 crossref_primary_10_3390_cancers10120488 crossref_primary_10_1016_j_modpat_2023_100274 crossref_primary_10_1016_S1632_3475_17_83974_6 crossref_primary_10_1016_j_ejca_2020_01_023 crossref_primary_10_1097_MD_0000000000005964 crossref_primary_10_1111_jop_13261 crossref_primary_10_1016_S1639_870X_17_84332_4 crossref_primary_10_1007_s00259_017_3737_x crossref_primary_10_1097_PAS_0000000000000945 crossref_primary_10_3389_fsurg_2021_799452 crossref_primary_10_5858_arpa_2018_0422_SA crossref_primary_10_6004_jnccn_2020_7593 crossref_primary_10_1002_hed_25942 crossref_primary_10_1111_cas_14790 crossref_primary_10_1002_dc_24573 crossref_primary_10_1007_s00428_017_2163_6 crossref_primary_10_1007_s12105_017_0801_6 crossref_primary_10_1186_s13014_022_02165_5 crossref_primary_10_1111_apm_12828 crossref_primary_10_1007_s00428_019_02617_6 crossref_primary_10_1016_j_canrad_2019_05_013 crossref_primary_10_1016_j_bbcan_2021_188523 crossref_primary_10_1111_apm_12901 crossref_primary_10_1016_j_oooo_2016_11_015 crossref_primary_10_1038_s41379_018_0005_y crossref_primary_10_1002_hed_26081 crossref_primary_10_1245_s10434_017_5862_y crossref_primary_10_1007_s00405_023_08252_x crossref_primary_10_1016_j_critrevonc_2022_103886 crossref_primary_10_1111_jcmm_13510 crossref_primary_10_5106_jjshns_30_297 crossref_primary_10_1016_j_oraloncology_2017_02_018 crossref_primary_10_1002_hed_24984 crossref_primary_10_3390_dj11110262 crossref_primary_10_1007_s00428_018_2349_6 crossref_primary_10_1007_s00405_020_06205_2 crossref_primary_10_1177_03000605221115151 crossref_primary_10_1200_JCO_21_00449 crossref_primary_10_1016_j_eucr_2023_102450 crossref_primary_10_1177_15330338231163026 crossref_primary_10_1111_his_13162 crossref_primary_10_18632_oncotarget_24800 crossref_primary_10_5812_ijcm_7485 crossref_primary_10_1002_lary_26516 crossref_primary_10_1007_s12105_022_01508_8 crossref_primary_10_1186_s40644_019_0190_z crossref_primary_10_1002_hed_27143 crossref_primary_10_1016_j_ijom_2022_05_005 crossref_primary_10_1093_carcin_bgac033 crossref_primary_10_1016_j_oraloncology_2023_106491 crossref_primary_10_1016_j_radonc_2022_03_005 crossref_primary_10_1002_hed_27307 crossref_primary_10_1016_j_oraloncology_2019_04_014 crossref_primary_10_1016_j_ijporl_2021_110637 crossref_primary_10_1007_s10147_020_01731_9 crossref_primary_10_1016_j_anndiagpath_2021_151867 crossref_primary_10_1158_2326_6066_CIR_16_0031 crossref_primary_10_1080_00016489_2017_1371329 crossref_primary_10_1053_j_semdp_2024_04_002 crossref_primary_10_3389_fimmu_2021_618367
Cites_doi	10.1016/j.amjoto.2011.11.006 10.1097/00005537-199709000-00022 10.1097/00005537-200407000-00012 10.1002/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9 10.1002/ijc.1013 10.1002/hed.23405 10.1002/cncr.21083 10.1016/j.oraloncology.2011.04.020 10.1097/COC.0b013e3181d26d45 10.1002/lary.20684 10.1001/archotol.125.2.149 10.1016/j.joms.2013.05.024 10.1054/ijom.2003.0448 10.1016/0360-3016(95)00122-F 10.1002/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E 10.1002/cncr.26549
ContentType	Journal Article
Copyright	Elsevier Ltd 2015 Elsevier Ltd Copyright © 2015 Elsevier Ltd. All rights reserved.
Copyright_xml	– notice: Elsevier Ltd – notice: 2015 Elsevier Ltd – notice: Copyright © 2015 Elsevier Ltd. All rights reserved.
DBID	CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8
DOI	10.1016/j.oraloncology.2015.10.002
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Dentistry
EISSN	1879-0593
EndPage	1142
ExternalDocumentID	10_1016_j_oraloncology_2015_10_002 26476712 S1368837515003322 1_s2_0_S1368837515003322
Genre	Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	--- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29N 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAWTL AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K X7M XPP Z5R ZGI ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8
ID	FETCH-LOGICAL-c501t-2b2ac7572c11453b96da254251eb8a50b3ff3525c799b0f20363fe78b7f93eb23
ISSN	1368-8375
IngestDate	Sat Oct 26 00:47:24 EDT 2024 Thu Sep 26 17:40:52 EDT 2024 Sat Sep 28 07:57:35 EDT 2024 Fri Feb 23 02:28:36 EST 2024 Tue Oct 15 22:57:15 EDT 2024
IsPeerReviewed	true
IsScholarly	true
Issue	12
Keywords	Prognosis Treatment National Radiotherapy Adenoid cystic carcinoma
Language	English
License	Copyright © 2015 Elsevier Ltd. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c501t-2b2ac7572c11453b96da254251eb8a50b3ff3525c799b0f20363fe78b7f93eb23
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ORCID	0000-0002-2476-1037
PMID	26476712
PQID	1737475309
PQPubID	23479
PageCount	5
ParticipantIDs	proquest_miscellaneous_1737475309 crossref_primary_10_1016_j_oraloncology_2015_10_002 pubmed_primary_26476712 elsevier_sciencedirect_doi_10_1016_j_oraloncology_2015_10_002 elsevier_clinicalkeyesjournals_1_s2_0_S1368837515003322
PublicationCentury	2000
PublicationDate	2015-12-01
PublicationDateYYYYMMDD	2015-12-01
PublicationDate_xml	– month: 12 year: 2015 text: 2015-12-01 day: 01
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England
PublicationTitle	Oral oncology
PublicationTitleAlternate	Oral Oncol
PublicationYear	2015
Publisher	Elsevier Ltd
Publisher_xml	– name: Elsevier Ltd
References	Amit, Binenbaum, Sharma, Ramer, Ramer, Agbetoba (b0070) 2014; 36 Fordice, Kershaw, El-Naggar, Goepfert (b0035) 1999; 125 Silverman, Carlson, Khuntia, Bergstrom, Saxton, Esclamado (b0080) 2004; 114 Nobis, Rohleder, Wolff, Wagenpfeil, Scherer, Kesting (b0090) 2014; 72 Barnes, Iveson, Reichart, Sidransky (b0015) 2005 Lloyd, Yu, Wilson, Decker (b0010) 2011; 34 Coupland, Sewpaul, Darne, White (b0060) 2014; 2014 Khan, DiGiovanna, Ross, Sasaki, Carter, Son (b0030) 2001; 96 Balamucki, Amdur, Werning, Vaysberg, Morris, Kirwan (b0095) 2012; 33 Bhayani, Yener, El-Naggar, Garden, Hanna, Weber (b0065) 2012; 118 Greene, Page, Fleming, Frita, Balch, Haller (b0020) 2002 Armstrong, Harrison, Thaler, Friedlander-Klar, Fass, Zelefsky (b0085) 1992; 69 Oplatek, Ozer, Agrawal, Bapna, Schuller (b0040) 2010; 120 Garden, Weber, Morrison, Ang, Peters (b0045) 1995; 32 Mendenhall, Morris, Amdur, Werning, Villaret (b0050) 2005; 103 Khafif, Anavi, Haviv, Fienmesser, Calderon, Marshak (b0055) 2005; 84 Sur, Donde, Levin, Pacella, Kotzen, Cooper (b0075) 1997; 107 Kokemueller, Eckardt, Brachvogel, Hausamen (b0100) 2004; 33 Bjorndal, Krogdahl, Therkildsen, Overgaard, Johansen, Kristensen (b0005) 2011; 47 Szanto, Luna, Tortoledo, White (b0025) 1984; 54 Szanto (10.1016/j.oraloncology.2015.10.002_b0025) 1984; 54 Oplatek (10.1016/j.oraloncology.2015.10.002_b0040) 2010; 120 Greene (10.1016/j.oraloncology.2015.10.002_b0020) 2002 Nobis (10.1016/j.oraloncology.2015.10.002_b0090) 2014; 72 Coupland (10.1016/j.oraloncology.2015.10.002_b0060) 2014; 2014 Balamucki (10.1016/j.oraloncology.2015.10.002_b0095) 2012; 33 Bjorndal (10.1016/j.oraloncology.2015.10.002_b0005) 2011; 47 Bhayani (10.1016/j.oraloncology.2015.10.002_b0065) 2012; 118 Lloyd (10.1016/j.oraloncology.2015.10.002_b0010) 2011; 34 Khafif (10.1016/j.oraloncology.2015.10.002_b0055) 2005; 84 Armstrong (10.1016/j.oraloncology.2015.10.002_b0085) 1992; 69 Khan (10.1016/j.oraloncology.2015.10.002_b0030) 2001; 96 Fordice (10.1016/j.oraloncology.2015.10.002_b0035) 1999; 125 Mendenhall (10.1016/j.oraloncology.2015.10.002_b0050) 2005; 103 Sur (10.1016/j.oraloncology.2015.10.002_b0075) 1997; 107 Barnes (10.1016/j.oraloncology.2015.10.002_b0015) 2005 Silverman (10.1016/j.oraloncology.2015.10.002_b0080) 2004; 114 Garden (10.1016/j.oraloncology.2015.10.002_b0045) 1995; 32 Amit (10.1016/j.oraloncology.2015.10.002_b0070) 2014; 36 Kokemueller (10.1016/j.oraloncology.2015.10.002_b0100) 2004; 33
References_xml	– volume: 33 start-page: 510 year: 2012 end-page: 518 ident: b0095 article-title: Adenoid cystic carcinoma of the head and neck publication-title: Am J Otolaryngol contributor: fullname: Kirwan – volume: 96 start-page: 149 year: 2001 end-page: 158 ident: b0030 article-title: Adenoid cystic carcinoma: a retrospective clinical review publication-title: Int J Cancer J Int Cancer contributor: fullname: Son – volume: 2014 start-page: 581823 year: 2014 ident: b0060 article-title: Adenoid cystic carcinoma of the submandibular gland, locoregional recurrence, and a solitary liver metastasis more than 30 years since primary diagnosis publication-title: Case Rep Surg contributor: fullname: White – volume: 120 start-page: 65 year: 2010 end-page: 70 ident: b0040 article-title: Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection publication-title: The Laryngoscope contributor: fullname: Schuller – volume: 32 start-page: 619 year: 1995 end-page: 626 ident: b0045 article-title: The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Peters – volume: 84 start-page: 4 year: 2005 end-page: 7 ident: b0055 article-title: Adenoid cystic carcinoma of the salivary glands: a 20-year review with long-term follow-up publication-title: Ear Nose Throat J contributor: fullname: Marshak – year: 2005 ident: b0015 article-title: World Health Organization classification of tumors: pathology and genetics of head and neck tumors contributor: fullname: Sidransky – volume: 33 start-page: 25 year: 2004 end-page: 31 ident: b0100 article-title: Adenoid cystic carcinoma of the head and neck–a 20 years experience publication-title: Int J Oral Maxillofac Surg contributor: fullname: Hausamen – volume: 47 start-page: 677 year: 2011 end-page: 682 ident: b0005 article-title: Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA) publication-title: Oral Oncol contributor: fullname: Kristensen – volume: 125 start-page: 149 year: 1999 end-page: 152 ident: b0035 article-title: Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality publication-title: Archiv Otolaryngol Head Neck Surg contributor: fullname: Goepfert – volume: 103 start-page: 2544 year: 2005 end-page: 2550 ident: b0050 article-title: Radiotherapy alone or combined with surgery for salivary gland carcinoma publication-title: Cancer contributor: fullname: Villaret – volume: 107 start-page: 1276 year: 1997 end-page: 1280 ident: b0075 article-title: Adenoid cystic carcinoma of the salivary glands: a review of 10 publication-title: The Laryngoscope contributor: fullname: Cooper – volume: 69 start-page: 615 year: 1992 end-page: 619 ident: b0085 article-title: The indications for elective treatment of the neck in cancer of the major salivary glands publication-title: Cancer contributor: fullname: Zelefsky – volume: 72 start-page: 205 year: 2014 end-page: 210 ident: b0090 article-title: Head and neck salivary gland carcinomas–elective neck dissection, yes or no? publication-title: J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg contributor: fullname: Kesting – volume: 118 start-page: 2872 year: 2012 end-page: 2878 ident: b0065 article-title: Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands publication-title: Cancer contributor: fullname: Weber – volume: 114 start-page: 1194 year: 2004 end-page: 1199 ident: b0080 article-title: Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck publication-title: The Laryngoscope contributor: fullname: Esclamado – volume: 36 start-page: 998 year: 2014 end-page: 1004 ident: b0070 article-title: Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study publication-title: Head Neck contributor: fullname: Agbetoba – volume: 34 start-page: 76 year: 2011 end-page: 81 ident: b0010 article-title: Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy publication-title: Am J Clin Oncol contributor: fullname: Decker – volume: 54 start-page: 1062 year: 1984 end-page: 1069 ident: b0025 article-title: Histologic grading of adenoid cystic carcinoma of the salivary glands publication-title: Cancer contributor: fullname: White – year: 2002 ident: b0020 article-title: American Joint Committee on Cancer. Cancer staging manual contributor: fullname: Haller – volume: 33 start-page: 510 year: 2012 ident: 10.1016/j.oraloncology.2015.10.002_b0095 article-title: Adenoid cystic carcinoma of the head and neck publication-title: Am J Otolaryngol doi: 10.1016/j.amjoto.2011.11.006 contributor: fullname: Balamucki – volume: 107 start-page: 1276 year: 1997 ident: 10.1016/j.oraloncology.2015.10.002_b0075 article-title: Adenoid cystic carcinoma of the salivary glands: a review of 10years publication-title: The Laryngoscope doi: 10.1097/00005537-199709000-00022 contributor: fullname: Sur – volume: 114 start-page: 1194 year: 2004 ident: 10.1016/j.oraloncology.2015.10.002_b0080 article-title: Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck publication-title: The Laryngoscope doi: 10.1097/00005537-200407000-00012 contributor: fullname: Silverman – volume: 69 start-page: 615 year: 1992 ident: 10.1016/j.oraloncology.2015.10.002_b0085 article-title: The indications for elective treatment of the neck in cancer of the major salivary glands publication-title: Cancer doi: 10.1002/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9 contributor: fullname: Armstrong – volume: 96 start-page: 149 year: 2001 ident: 10.1016/j.oraloncology.2015.10.002_b0030 article-title: Adenoid cystic carcinoma: a retrospective clinical review publication-title: Int J Cancer J Int Cancer doi: 10.1002/ijc.1013 contributor: fullname: Khan – volume: 36 start-page: 998 year: 2014 ident: 10.1016/j.oraloncology.2015.10.002_b0070 article-title: Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study publication-title: Head Neck doi: 10.1002/hed.23405 contributor: fullname: Amit – volume: 103 start-page: 2544 year: 2005 ident: 10.1016/j.oraloncology.2015.10.002_b0050 article-title: Radiotherapy alone or combined with surgery for salivary gland carcinoma publication-title: Cancer doi: 10.1002/cncr.21083 contributor: fullname: Mendenhall – volume: 47 start-page: 677 year: 2011 ident: 10.1016/j.oraloncology.2015.10.002_b0005 article-title: Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA) publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2011.04.020 contributor: fullname: Bjorndal – volume: 34 start-page: 76 year: 2011 ident: 10.1016/j.oraloncology.2015.10.002_b0010 article-title: Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy publication-title: Am J Clin Oncol doi: 10.1097/COC.0b013e3181d26d45 contributor: fullname: Lloyd – year: 2005 ident: 10.1016/j.oraloncology.2015.10.002_b0015 contributor: fullname: Barnes – volume: 120 start-page: 65 year: 2010 ident: 10.1016/j.oraloncology.2015.10.002_b0040 article-title: Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection publication-title: The Laryngoscope doi: 10.1002/lary.20684 contributor: fullname: Oplatek – volume: 2014 start-page: 581823 year: 2014 ident: 10.1016/j.oraloncology.2015.10.002_b0060 article-title: Adenoid cystic carcinoma of the submandibular gland, locoregional recurrence, and a solitary liver metastasis more than 30 years since primary diagnosis publication-title: Case Rep Surg contributor: fullname: Coupland – volume: 125 start-page: 149 year: 1999 ident: 10.1016/j.oraloncology.2015.10.002_b0035 article-title: Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality publication-title: Archiv Otolaryngol Head Neck Surg doi: 10.1001/archotol.125.2.149 contributor: fullname: Fordice – volume: 72 start-page: 205 year: 2014 ident: 10.1016/j.oraloncology.2015.10.002_b0090 article-title: Head and neck salivary gland carcinomas–elective neck dissection, yes or no? publication-title: J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg doi: 10.1016/j.joms.2013.05.024 contributor: fullname: Nobis – volume: 33 start-page: 25 year: 2004 ident: 10.1016/j.oraloncology.2015.10.002_b0100 article-title: Adenoid cystic carcinoma of the head and neck–a 20 years experience publication-title: Int J Oral Maxillofac Surg doi: 10.1054/ijom.2003.0448 contributor: fullname: Kokemueller – volume: 32 start-page: 619 year: 1995 ident: 10.1016/j.oraloncology.2015.10.002_b0045 article-title: The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(95)00122-F contributor: fullname: Garden – year: 2002 ident: 10.1016/j.oraloncology.2015.10.002_b0020 contributor: fullname: Greene – volume: 54 start-page: 1062 year: 1984 ident: 10.1016/j.oraloncology.2015.10.002_b0025 article-title: Histologic grading of adenoid cystic carcinoma of the salivary glands publication-title: Cancer doi: 10.1002/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E contributor: fullname: Szanto – volume: 84 start-page: 4 issue: 662 year: 2005 ident: 10.1016/j.oraloncology.2015.10.002_b0055 article-title: Adenoid cystic carcinoma of the salivary glands: a 20-year review with long-term follow-up publication-title: Ear Nose Throat J contributor: fullname: Khafif – volume: 118 start-page: 2872 year: 2012 ident: 10.1016/j.oraloncology.2015.10.002_b0065 article-title: Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands publication-title: Cancer doi: 10.1002/cncr.26549 contributor: fullname: Bhayani
SSID	ssj0005150
Score	2.4410522
Snippet	Highlights • A national Danish study presenting 201 patients with adenoid cystic carcinoma. • 10-year disease specific survival was 75%. • 36% experienced... •A national Danish study presenting 201 patients with adenoid cystic carcinoma.•10-year disease specific survival was 75%.•36% experienced recurrence during... To describe outcome and prognostic factors, including the effect of radiotherapy, in a consecutive national series of salivary gland adenoid cystic carcinomas.... AIMTo describe outcome and prognostic factors, including the effect of radiotherapy, in a consecutive national series of salivary gland adenoid cystic...
SourceID	proquest crossref pubmed elsevier
SourceType	Aggregation Database Index Database Publisher
StartPage	1138
SubjectTerms	Adenoid cystic carcinoma Adolescent Adult Aged Aged, 80 and over Carcinoma, Adenoid Cystic - mortality Carcinoma, Adenoid Cystic - therapy Child Denmark - epidemiology Female Hematology, Oncology and Palliative Medicine Humans Male Middle Aged National Neoplasm Recurrence, Local - mortality Otolaryngology Prognosis Radiotherapy Radiotherapy, Adjuvant Salivary Gland Neoplasms - mortality Salivary Gland Neoplasms - therapy Survival Analysis Treatment Young Adult
Title	Salivary adenoid cystic carcinoma in Denmark 1990–2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)
URI	https://www.clinicalkey.es/playcontent/1-s2.0-S1368837515003322 https://dx.doi.org/10.1016/j.oraloncology.2015.10.002 https://www.ncbi.nlm.nih.gov/pubmed/26476712 https://search.proquest.com/docview/1737475309
Volume	51
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELbaIgEXBAXK8icjcQCtsortONkgcdg_VKlqK9EiIS6R80fTbhOU3T3sjXfgnXgQnoSZ2N5sgZUKEpdolTiJs_PNeDz-ZkzISzB3buoLz8l8xR2P5b4Tigz0qs9YGCd-zGNc0d0_CY4-9scTb7K1bZPC2nP_VdJwDmSNmbN_Ie3VQ-EE_AaZwxGkDsdryf1E4eJOvewqsChVkXaTJZZixhLUSVFWlwojHOOsvFT1RZfBKGHpDgIjPxggOF7MoWNmWWG1S-68oXKVVfMwu0tPUSbTRWozrmKwm3nRUAtqlRYmt2vZwzWCxVSTRrAdprXPzjADqqkTC4Y2ueiOEH61CY6B2zse7A-ORgMbqTD-8zHWE6jK5MpiwPAcl_uH_bpM1bS1XC1h4AB6nqozzUdAYk_RLkmBntQXxTQ1kahDBTKCJm3SBhISVNyQHoZF_bmw1CgTKmFyjXairbvw-w7MyOW6-ZdsHeZ8zZgzpgvPGMcAs47_OOjo-Md5D0sq2H8ASYOy1_AGeTvUWnrBZHTAnBnvuc4J9gm7BI65KwT_pbGep0UzHrnRb023yQ0O5hWt-yf5viU2Malz483H2lK7DatxUx83uWWbpl2N-3V6l9wx8yY60IC_R7aycpfcGiPXDbcr3CU3Dw1L5D75bnWAGh2gWgfoSgdoUVKjAxR14MfXb4j-N9RgnwIs6Rr2aYt9arBPV9ingGlqsE-rnF7BPjXYxwvYTmOfIvablyD2qcY-bbBPXxnkv35APrybnI72HbNfiZNIl80dHnOVBDLgCUBFijj0U8UlDIosi_tKurHIc6w-nARhGLs5UgBEngX9OMjBPsZcPCQ7ZVVmjwj1coxZhTDfEpnnwd0h-OEK9-dVMlM87hBhxRV90WVpIsvXPI_WhRyhkPEaCLlDAivZyCZeg6uQzYz9mkWboNYhb1d3Gtdcu9wRKMG13vzCAimC8QsXJVWZVQt4YyACL5DCDTtkTyNs9UUwWQv8gPHH_9zvJ-R2awiekp15vcieke1ZunjeKM1PrdYbRw
link.rule.ids	315,782,786,27933,27934
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Salivary+adenoid+cystic+carcinoma+in+Denmark+1990%E2%80%932005%3A+Outcome+and+independent+prognostic+factors+including+the+benefit+of+radiotherapy.+Results+of+the+Danish+Head+and+Neck+Cancer+Group+%28DAHANCA%29&rft.jtitle=Oral+oncology&rft.au=Bj%C3%B8rndal%2C+Kristine&rft.au=Krogdahl%2C+Annelise&rft.au=Therkildsen%2C+Marianne+H&rft.au=Charabi%2C+Birgitte&rft.date=2015-12-01&rft.issn=1368-8375&rft.volume=51&rft.issue=12&rft.spage=1138&rft.epage=1142&rft_id=info:doi/10.1016%2Fj.oraloncology.2015.10.002&rft.externalDBID=ECK1-s2.0-S1368837515003322&rft.externalDocID=1_s2_0_S1368837515003322
thumbnail_m	http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F13688375%2FS1368837515X0011X%2Fcov150h.gif